Results 201 to 210 of about 910,182 (402)

POSTOPERATIVE VOMITING

open access: bronze, 1957
R. Burtles, B. W. Peckett
openalex   +1 more source

UGT1A1 and Sacituzumab Govitecan Toxicity: A Systematic Review and Meta‐Analysis

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Sacituzumab govitecan (SG), a humanized antibody‐drug conjugate, enables intra‐tumor delivery of SN‐38, the active metabolite of irinotecan, with the aim of increasing efficacy. SN‐38 is predominantly inactivated by the polymorphically expressed uridine diphosphate glucuronosyltransferase 1A1 (UGT1AA) where reduced activity can lead to toxicity.
Cinzia Dello Russo   +4 more
wiley   +1 more source

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.

open access: yesAnnals of Oncology, 2016
F. Roila   +18 more
semanticscholar   +1 more source

Trajectories of Childhood Adversity and Eating Disorders in Adolescence

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Childhood adversities are linked to eating disorders (EDs), but their cumulative and evolving nature is often overlooked. This study employs a comprehensive measure of adversities, captured through trajectories across ages 0–9, to examine associations with (1) clinically diagnosed EDs at ages 10–18 and (2) a composite outcome of ...
Andrea Joensen   +5 more
wiley   +1 more source

A Pilot Evaluation of a Focused Acceptance and Commitment Therapy Program for Individuals With an Eating Disorder Waitlisted for Treatment

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Increasing demand for eating disorder treatment services has placed pressure on service capacity and extended wait times. Although wait times have been associated with treatment disengagement, there is limited evidence for interventions to mitigate their impact for adults with eating disorders.
Jessica Tone   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy